Literature DB >> 6327507

Development and properties of a monoclonal antibody specific for human ecto-5'-nucleotidase.

U Kummer, J Mysliwietz, W Gutensohn, S Buschette, H Jahn, D Neuser, R Munker.   

Abstract

After immunization with purified human placental ecto-5'-nucleotidase and fusion, 18 different hybrids were obtained which produce an antibody inhibitory for enzyme activity. These antibodies show complete cross-reactivity with the enzyme in a membrane-bound form or on the surface of intact cells. After cloning and ascites production, the antibody of one clone ( IFH - 5N1 ) was studied in greater detail. The IFH - 5N1 antibody is of the IgG 1 subclass. Optimal enzyme inhibition is 90% for purified 5'-nucleotidase and 80% for the enzyme on lymphoblasts. The specificity of this antibody is further demonstrated by enzyme inhibition assays and fluorescence labeling using various 5'-nucleotidase-positive and -negative human cells such as peripheral blood lymphocytes, leukemic cells, lymphoblastoid B- and T-cell-lines and fibroblasts. The antibody should provide a useful tool for the diagnosis of certain forms of acute leukemias and for the study of normal human lymphocyte subpopulations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6327507     DOI: 10.1016/S0171-2985(84)80038-8

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  1 in total

1.  Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.

Authors:  K H Krüger; L F Thompson; M Kaufmann; P Möller
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.